Literature DB >> 24324047

Targeting the sympathetic nervous system: critical issues in patient selection, efficacy, and safety of renal denervation.

Markus P Schlaich1, Murray D Esler, Greg D Fink, John W Osborn, David E Euler.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24324047     DOI： 10.1161/HYPERTENSIONAHA.113.02144

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  12 in total

1.  Afferent innervation of the ischemic kidney contributes to renal dysfunction in renovascular hypertensive rats.

Authors:  Nathalia R Lopes; Maycon I O Milanez; Beatriz S Martins; Amanda C Veiga; Giovanna R Ferreira; Guiomar N Gomes; Adriana C Girardi; Polliane M Carvalho; Fernando N Nogueira; Ruy R Campos; Cássia T Bergamaschi; Erika E Nishi
Journal:  Pflugers Arch       Date:  2020-01-10       Impact factor: 3.657

2.  Renal nerves: time for reassessment of their role in hypertension?

Authors:  Gregory D Fink; John W Osborn
Journal:  Am J Hypertens       Date:  2014-05-28       Impact factor: 2.689

3.  Renal sympathetic nerve activity regulates cardiovascular energy expenditure in rats fed high salt.

Authors:  Norihiko Morisawa; Kento Kitada; Yoshihide Fujisawa; Daisuke Nakano; Daisuke Yamazaki; Shuhei Kobuchi; Lei Li; Yifan Zhang; Takashi Morikawa; Yoshio Konishi; Takashi Yokoo; Friedrich C Luft; Jens Titze; Akira Nishiyama
Journal:  Hypertens Res       Date:  2020-01-14       Impact factor: 3.872

Review 4.  Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.

Authors:  Thierry H Le Jemtel; William Richardson; Rohan Samson; Abhishek Jaiswal; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

5.  The thrill of success: central arterial-venous anastomosis for hypertension.

Authors:  Marat Fudim; Alice Stanton; Paul A Sobotka; Eamon Dolan; Henry Krum
Journal:  Curr Hypertens Rep       Date:  2014-12       Impact factor: 5.369

Review 6.  Gut microbiota in hypertension.

Authors:  Pedro A Jose; Dominic Raj
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-09       Impact factor: 2.894

Review 7.  The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease.

Authors:  Ines Armando; Prasad Konkalmatt; Robin A Felder; Pedro A Jose
Journal:  Transl Res       Date:  2014-07-25       Impact factor: 7.012

Review 8.  Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.

Authors:  Alexandre Persu; Sverre Kjeldsen; Jan A Staessen; Michel Azizi
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

9.  Renal denervation in less severe forms of (resistant) hypertension-Quo vadis?

Authors:  Markus P Schlaich; Dagmara Hering; Yusuke Sata
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-04       Impact factor: 3.738

Review 10.  Controversies Surrounding Renal Denervation: Lessons Learned From Real-World Experience in Two United Kingdom Centers.

Authors:  Amy E Burchell; Kenneth Chan; Laura E K Ratcliffe; Emma C Hart; Manish Saxena; David J Collier; Ajay K Jain; Anthony Mathur; Charles J Knight; Mark J Caulfield; Julian F R Paton; Angus K Nightingale; Melvin D Lobo; Andreas Baumbach
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-02-09       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.